You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TB/HIV coinfection

Showing 1 - 25 of 8,950
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Contributing Factors for Poor HIV Treatment Response in TB/HIV

Recruiting
  • Tuberculosis
  • +2 more
  • Observational study
  • Kumasi, Ghana
    Kwame Nkrumah University of Science and Technology
Mar 23, 2022

Tuberculosis, HIV Coinfection, Tuberculosis Infection Trial (patient-centered TB preventive therapy, TB preventive therapy

Not yet recruiting
  • Tuberculosis
  • +2 more
  • patient-centered TB preventive therapy
  • TB preventive therapy adherence support
  • (no location specified)
Apr 21, 2022

Tuberculosis, HIV Coinfection, Diagnoses Disease Trial (Concentrated urine with Xpert Ultra, Stool with Xpert Ultra)

Recruiting
  • Tuberculosis
  • +2 more
  • Concentrated urine with Xpert Ultra
  • Stool with Xpert Ultra
  • Manhiça, Vila Da Manhiça, Mozambique
  • +3 more
Nov 30, 2022

Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)

Recruiting
  • Tuberculosis
  • +2 more
  • Johannesburg, Gauteng, South Africa
    Tembisa Clinical Research Centre-The Aurum Institute
Jun 8, 2022

HIV/TB Coinfection Trial in Thailand (DTG 50 mg OD with food, DTG 50 mg BID)

Recruiting
  • HIV/TB Coinfection
  • DTG 50 mg OD with food
  • DTG 50 mg BID
  • Chiang Rai, Chiangrai, Thailand
  • +9 more
Mar 22, 2022

MDR-TB, HIV Trial in South Africa (NCM-Plus)

Active, not recruiting
  • MDR-TB
  • HIV
  • NCM-Plus
  • Westville, Durban, South Africa
  • +14 more
Nov 16, 2021

Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents

Recruiting
  • Human Immunodeficiency Virus (HIV)
  • +2 more
  • Observational PK study
  • Kumasi, Ghana
    Kwame Nkrumah University of Science and Technology
Jun 13, 2022

Adequacy of New Pediatric Isoniazid/Rifampin/Pyrazinamide Tablet

Recruiting
  • Tuberculosis
  • +2 more
  • Observational PK study
  • Kumasi, Ghana
    Kwame Nkrumah University of Science and Technology
Dec 21, 2022

Tuberculosis, HIV Trial in Kampala (Standard TB-EC, Peer navigation strategy for TB-EC)

Not yet recruiting
  • Tuberculosis
  • HIV
  • Standard TB-EC
  • Peer navigation strategy for TB-EC
  • Kampala, Uganda
    Primary Care Clinics
Jun 14, 2023

HIV, Tuberculosis, Smoking Cessation Trial in Rondebosch (QUIT-AD, Enhanced Treatment as Usual)

Not yet recruiting
  • HIV Infections
  • +2 more
  • QUIT-AD
  • Enhanced Treatment as Usual
  • Rondebosch, South Africa
    University of Cape Town
Apr 24, 2023

Mpox in HIV Negative High Risk Sexual Health Clinic Attenders

Not yet recruiting
  • Monkeypox
  • HIV Coinfection
  • No intervention
  • (no location specified)
Jul 19, 2023

Tuberculosis, Hiv Trial (CAP, Usual Care)

Not yet recruiting
  • Tuberculosis
  • Hiv
  • CAP
  • Usual Care
  • (no location specified)
Aug 10, 2022

Adherence, Patient, TB, HIV/AIDS Trial in Baltimore (CHW mHealth patient intervention for trigger escalation)

Recruiting
  • Adherence, Patient
  • +3 more
  • CHW mHealth patient intervention for trigger escalation
  • Baltimore, Maryland
    Kelly Lowensen
Mar 10, 2022

HIV Coinfection Trial in Lilongwe (Antiparasitic medication)

Recruiting
  • HIV Coinfection
  • Antiparasitic medication
  • Lilongwe, Malawi
    Lighthouse Clinic
May 10, 2022

Self-collected Vaginal and Urine Samples in HIV-positive Women

Not yet recruiting
  • HIV Infections
  • +3 more
  • Self-sampling for HPV infection
  • (no location specified)
Mar 13, 2023

Hiv, Tuberculosis, Social Behavior Trial in Kampala (Social Support)

Completed
  • Hiv
  • +4 more
  • Social Support
  • Kampala, Uganda
    Makerere University
Sep 13, 2022

Human Immunodeficiency Virus (HIV) Infection Trial in Maseru, Blantyre (ART first- Therapeutic use trial, TB results first-

Recruiting
  • Human Immunodeficiency Virus (HIV) Infection
  • ART first- Therapeutic use trial
  • TB results first- Therapeutic use trial
  • Maseru, Lesotho
  • +1 more
Aug 10, 2022

HIV, Tuberculosis Trial in Worldwide (Efavirenz (EFV), Rifampin-containing anti-TB therapy)

Completed
  • HIV Infections
  • Tuberculosis
  • Efavirenz (EFV)
  • Rifampin-containing anti-TB therapy
  • Pune, Maharashtra, India
  • +6 more
Oct 28, 2021

Drug-resistant Tuberculosis, HIV Coinfection, Cost-Benefit Analysis Trial in Cape Town (Targeted next-generation sequencing)

Not yet recruiting
  • Drug-resistant Tuberculosis
  • +2 more
  • Targeted next-generation sequencing
  • Cape Town, South Africa
    South African National Health Laboratory Service
Sep 23, 2022

Promoting Engagement in Drug Resistant TB/HIV Care Continuum in

Completed
  • Patient Non-compliance
    • Durban, Kwa-Zulu Natal, South Africa
      King Dinuzulu Hospital
    Jul 19, 2022

    Pre-exposure Prophylaxis, HIV Trial in Cape Town (Social Media Campaign, PrEP Champions, Community Mobilization)

    Recruiting
    • Pre-exposure Prophylaxis
    • HIV Infections
    • Social Media Campaign
    • +2 more
    • Cape Town, Western Cape, South Africa
      TB HIV Care
    Oct 24, 2022

    Tuberculosis Trial in Louis Trichardt, Mokopane (Active TB case finding)

    Completed
    Has Results
    • Tuberculosis
    • Active TB case finding
    • Louis Trichardt, Limpopo, South Africa
    • +1 more
    Nov 16, 2022

    Host Blood RNA Signatures for Diagnosis of TB (RADIANT)

    Recruiting
    • Tuberculosis
    • NanoString nCounter assay
    • Cape Town, Western Cape, South Africa
    • +1 more
    Sep 12, 2022

    Tuberculosis, HIV/AIDS Trial in Kampala (SPIRIT Intervention)

    Active, not recruiting
    • Tuberculosis
    • HIV/AIDS
    • SPIRIT Intervention
    • Kampala, Uganda
      Infectious Diseases Research Collaboration
    Oct 14, 2022

    COVID-19 Trial in Yaoundé, Nairobi (Integration of SARS-CoV 2 Testing in HIV, MNCH and TB Clinics)

    Not yet recruiting
    • COVID-19
    • Integration of SARS-CoV 2 Testing in HIV, MNCH and TB Clinics
    • Yaoundé, Cameroon
    • +1 more
    Aug 16, 2022